Skip to content
Delayed ~15 min

IDYA IDEAYA BIOSCIENCES

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 19 analyst firms say about IDEAYA BIOSCIENCES: their latest ratings, price targets and how far the stock is from them. How it works

31.24 USD+0.59 (+1.93%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+55.6%to the avg target 48.63 USD+17.39 USD
Buy 15 · Hold 4 · Sell 0

19 rated views · 21 analyst/firm records · 19 firms

Latest report29 Oct 2026avg report date 10 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8078
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8069

Recent analyst activity · last 90 days

Our tracked history has 17 reports on IDYA from 12 analyst firms in the last 90 days (19 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 4 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Citigroup raised its target from $65.00 (set 1 Sep 2026) to $66.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldLi WatsekBuy22 Sep 2026—
CitigroupYigal NochomovitzBuy1 Sep 202665.00 USD
Citizens JMPSilvan C TuerkcanBuy6 Aug 202642.00 USD
Citizens JMPSilvan TurkcanBuy1 Sep 202642.00 USD
Goldman SachsCorinne JenkinsHold14 Apr 202635.00 USD
Goldman SachsCorinne JohnsonHold14 Apr 202636.00 USD
GuggenheimPaul JengBuy9 Sep 202657.00 USD
JefferiesMaury RaycroftBuy5 Aug 202651.00 USD
Leerink PartnersAndrew BerensHold5 Aug 202631.00 USD
Lifesci CapitalCharles ZhuBuy8 Aug 202662.00 USD
MizuhoGraig SuvannavejhConflictConflicting reports · excluded29 Oct 202644.00 USD
RBC Capital MarketsLeonid TimashevBuy7 Jul 202648.00 USD
StifelLaura PrendergastBuy14 Oct 202648.00 USD
TD CowenTyler Van BurenBuy15 Jun 2026—
TruistGregory RenzaBuy5 Aug 202659.00 USD
UBSMichael J YeeBuy5 Aug 202650.00 USD
WedbushRobert DriscollBuy26 Oct 202660.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Wells FargoEva Fortea-VerdejoBuy5 Aug 202648.00 USD
William BlairAlethia YoungBuy16 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 04:44 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.